£36 million boost for AI technologies to revolutionise NHS care
Thousands of patients and NHS staff will benefit from dozens of new pioneering projects awarded a share of £36 million to test state-of-the-art AI technology. The projects will help the NHS to transform the quality of care and the speed of diagnoses for conditions such as lung cancer.
Read the full article and watch the video on NHS England.
Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation
Press Release Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (LODOCO®– colchicine, 0.5 mg…
American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI
Press Release Caristo’s AI Technology for Coronary Inflammation Measurement and Risk Assessment Can Transform Risk Stratification and Management of Patients…